The 33rd Annual Meeting of Japan Society of Gene and Cell Therapy【Fukuoka Prefecture】

Meeting Theme and Objectives

A New Stage in Gene and Cell Therapy: From Clinical Implementation to the Future of Medicine (translated from the official Japanese theme)

Gene and cell therapies have progressed from experimental research to clinical treatment options. Against the background of advances in ex vivo gene therapy, including CAR-T cell products, in vivo gene therapy and iPS cell-derived regenerative medicine products, the 33rd annual meeting will address the challenges of bringing innovative treatments to more patients with intractable diseases.

The meeting will bring together participants from academia, industry and government to discuss future developments across basic research, clinical development, manufacturing, quality control, regulation and healthcare access.

Official information: President’s Message (Japanese)

33rd Annual Meeting of Japan Society of Gene and Cell Therapy: Event Information

• Official English Name: The 33rd Annual Meeting of Japan Society of Gene and Cell Therapy
• Japanese Name: 第33回日本遺伝子細胞治療学会学術集会
• Abbreviation: JSGCT2027
• Dates: July 13–15, 2027 (Tuesday–Thursday)
• Educational Program: July 12, 2027 (Monday), at Fukuoka International Congress Center
• Venue: Fukuoka International Congress Center
• Address: 2-1 Sekijo-machi, Hakata-ku, Fukuoka 812-0032, Japan
• Organizer: Japan Society of Gene and Cell Therapy (JSGCT)
• Meeting Format: In-person meeting (planned)
• Expected Attendance: Approximately 700 participants (organizer’s estimate in the sponsorship prospectus)

Official information: Official Meeting Website / JSGCT Annual Meetings (Japanese)

Meeting Organization

• Meeting President: Dr. Yasuhiro Ikeda, Professor of Ophthalmology, Faculty of Medicine, University of Miyazaki
• Meeting Secretariat: Department of Ophthalmology, Faculty of Medicine, University of Miyazaki
• Secretariat Address: 5200 Kihara, Kiyotake-cho, Miyazaki 889-1692, Japan
• Administrative Secretariat: Convention Linkage, Inc.
• Tel: +81-92-437-4188
• Fax: +81-92-437-4182
• Email: jsgct2027@c-linkage.co.jp

Official information: President’s Message and Secretariat (Japanese)

Key Research Areas and Highlights

The president’s message and the official sponsorship prospectus identify a broad range of research and business areas related to clinical applications and future advances in gene and cell therapy.

• Gene Therapy: In vivo and ex vivo gene therapy, and treatment development for inherited and intractable diseases.
• Cell Therapy and Regenerative Medicine: CAR-T cell therapy and regenerative medicine products derived from induced pluripotent stem cells (iPS cells).
• Vector and Cell Product Manufacturing: Production and quality control of gene therapy vectors and cell-based products.
• Clinical Development and Safety Assessment: Evaluation of treatment effectiveness and safety in real-world clinical practice.
• Nucleic Acid Therapeutics and Genome Editing: Scientific exchange on advanced therapeutic technologies through joint sessions with related societies.
• Clinical Implementation: Regulation, healthcare access, treatment costs, workforce development and genetic counseling.
• Ophthalmology: Gene therapy for inherited retinal diseases and regenerative medicine for intractable corneal disorders.

Pharma Nexus highlights: The meeting offers researchers and companies working with vector manufacturing, cell culture, single-use technologies, cell processing, purification, analytical instruments and quality assessment an opportunity to understand challenges in gene and cell therapy development and manufacturing. These are related areas of interest, not confirmed individual presentations or exhibited products.

Official information: President’s Message (Japanese) / Japan Society of Gene and Cell Therapy

Call for Abstracts

As of November 13, 2026, formal guidelines for general abstract submissions, including submission dates, eligibility, abstract requirements and presentation formats, have not been confirmed on the official website. These details are under preparation and should be checked once the official announcement becomes available.

The sponsorship prospectus includes general presentations on each meeting day, but submission deadlines and acceptance notification dates have not been confirmed. Abstract submission requirements from previous meetings have not been applied.

Official information: Official Meeting Website and Latest Announcements

Program and Schedule

The official sponsorship prospectus outlines the following preliminary program. Please consult the finalized scientific program for individual speakers, presentation titles and detailed session times.

• July 12 (Monday): Educational program.
• July 13 (Tuesday): Opening ceremony, society leadership lecture, special and educational lectures, plenary sessions, a joint session with the Japanese Society for Regenerative Medicine, ASGCT/ESGCT/JSGCT joint symposium, industry-sponsored seminars and general presentations.
• July 14 (Wednesday): International invited lectures, vice president’s symposium, joint sessions with the Japanese Society of Nucleic Acid Therapeutics and the Japanese Society for Virology, dialogue sessions, educational lectures, general presentations and Get Together.
• July 15 (Thursday): International invited lectures, a debate on regenerative medicine and gene therapy, a joint session with the Japanese Society of Child Neurology, genetic counseling in gene therapy, a joint session with the Japanese Society for Genome Editing, an early-career researcher symposium, educational lectures, general presentations and closing ceremony.

The joint symposium with the American Society of Gene & Cell Therapy (ASGCT) and the European Society of Gene & Cell Therapy (ESGCT) is a notable opportunity for international scientific exchange. All program items listed above are preliminary and subject to change.

Official information: Official Sponsorship Prospectus (PDF, Japanese) and Preliminary Program / Official Meeting Website

Registration and Fees

Registration opening and closing dates, as well as fees for members, nonmembers and students, have not been confirmed on the official website. The formal registration instructions are under preparation.

The meeting is planned as an in-person event. Please consult the forthcoming official instructions for educational program eligibility, separate registration requirements and fees for July 12, Get Together registration, and any online streaming arrangements.

Official information: Registration and Latest Announcements

Corporate Sponsorship and Exhibition Opportunities (Applications Open)

Applications are open for corporate exhibitions, book exhibitions, co-sponsored seminars and advertising opportunities. The meeting provides manufacturers and suppliers of medical equipment, pharmaceuticals and reagents with opportunities to introduce their technologies to researchers and healthcare professionals in gene and cell therapy.

Key Sponsorship Fees (Including Tax)

• Corporate Exhibition, Standard Booth: JPY 275,000 per booth.
• Corporate Exhibition, Space-only Booth: JPY 1,100,000 per set of four booths.
• Book Exhibition: JPY 33,000 per table.
• Luncheon Seminar A: JPY 1,980,000.
• Luncheon Seminar B: JPY 1,650,000.
• Morning, Evening and Sponsored Seminars: JPY 880,000 each.
• Pocket Program Advertising: JPY 77,000–220,000.
• Website Banner Advertising: JPY 110,000.
• Intermission Slide Advertising: JPY 165,000.

Exhibition and Booth Specifications

• Exhibition Venue: Multipurpose Hall, second floor, Fukuoka International Congress Center.
• Standard Booth: 1,800 mm W × 900 mm D × 2,100 mm H. A display table, back panel, fluorescent light and company name sign are planned.
• Space-only Booth: 1,800 mm W × 900 mm D per booth. Applications are made in sets of four booths.
• Move-in and Setup: July 12, 13:00–17:00 (tentative).
• Exhibition Hours: July 13–15, 8:00–17:00 each day (tentative).
• Dismantling and Move-out: July 15, 17:00–19:00 (tentative).

Application Deadlines: March 1, 2027 (Monday), for co-sponsored seminars; April 12, 2027 (Monday), for corporate and book exhibitions and advertising. Applications may close early when capacity is reached.

Seminar fees include the venue and basic presentation equipment, while meals, beverages, speaker expenses, additional equipment and event staff incur separate costs. Exhibition electricity and rental equipment are optional extras. Please review the official sponsorship prospectus for full terms, including cancellation restrictions and confirmation of sponsorship allocations.

Sponsorship Secretariat: Convention Linkage, Inc. Tel: +81-92-437-4188 / Email: sp_jsgct2027@c-linkage.co.jp

Official information: Sponsorship and Exhibition Applications (Japanese) / Official Sponsorship Prospectus (PDF, Japanese)

Venue and Access

Fukuoka International Congress Center
2-1 Sekijo-machi, Hakata-ku, Fukuoka 812-0032, Japan

Located in Hakata, Fukuoka, the venue hosts international conferences and academic meetings in medicine and the life sciences. Please consult the official meeting access page and the venue website for transportation details, facility information and floor guides.

Official information: Fukuoka International Congress Center / Official Meeting Access Information (English)

Official Websites

JSGCT2027 Official Meeting Website

President’s Message (Japanese)

Sponsorship and Exhibition (Japanese)

Sponsorship Prospectus (PDF, Japanese)

Japan Society of Gene and Cell Therapy (English)

JSGCT Annual Meetings (Japanese)

Meeting Access Information (English)

Fukuoka International Congress Center

Information checked November 13, 2026. Meeting details, programs, sponsorship fees and application deadlines are subject to change. Please consult the official meeting website for the latest information.